BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 9396692)

  • 1. Microbiologic approaches for studying Campylobacter species in patients with Guillain-Barré syndrome.
    Nachamkin I
    J Infect Dis; 1997 Dec; 176 Suppl 2():S106-14. PubMed ID: 9396692
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guillain-Barré syndrome in South Africa associated with Campylobacter jejuni O:41 strains.
    Lastovica AJ; Goddard EA; Argent AC
    J Infect Dis; 1997 Dec; 176 Suppl 2():S139-43. PubMed ID: 9396698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Campylobacter jejuni isolates from Japanese patients with Guillain-Barré syndrome.
    Saida T; Kuroki S; Hao Q; Nishimura M; Nukina M; Obayashi H
    J Infect Dis; 1997 Dec; 176 Suppl 2():S129-34. PubMed ID: 9396696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Campylobacter jejuni strains from patients with Guillain-Barré syndrome.
    Allos BM; Lippy FT; Carlsen A; Washburn RG; Blaser MJ
    Emerg Infect Dis; 1998; 4(2):263-8. PubMed ID: 9621196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between Campylobacter infection and Guillain-Barré syndrome.
    Allos BM
    J Infect Dis; 1997 Dec; 176 Suppl 2():S125-8. PubMed ID: 9396695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Campylobacter jejuni by culture and real-time PCR in a French cohort of patients with Guillain-Barre syndrome.
    Sivadon-Tardy V; Orlikowski D; Porcher R; Ronco E; Caudie C; Roussi J; Fauchère JL; Mégraud F; Tabor H; Sharshar T; Annane D; Raphaël JC; Gaillard JL
    J Clin Microbiol; 2010 Jun; 48(6):2278-81. PubMed ID: 20410350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Workshop summary and recommendations regarding the development of Guillain-Barré syndrome following Campylobacter infection.
    Lang DR; Allos BM; Blaser MJ
    J Infect Dis; 1997 Dec; 176 Suppl 2():S198-200. PubMed ID: 9396711
    [No Abstract]   [Full Text] [Related]  

  • 8. Campylobacter 0:41 isolation in Guillain-Barré syndrome.
    Goddard EA; Lastovica AJ; Argent AC
    Arch Dis Child; 1997 Jun; 76(6):526-8. PubMed ID: 9245852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Campylobacter species and Guillain-Barré syndrome.
    Nachamkin I; Allos BM; Ho T
    Clin Microbiol Rev; 1998 Jul; 11(3):555-67. PubMed ID: 9665983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specific serotype of Campylobacter jejuni associated with Guillain-Barré syndrome.
    Fujimoto S; Yuki N; Itoh T; Amako K
    J Infect Dis; 1992 Jan; 165(1):183. PubMed ID: 1727892
    [No Abstract]   [Full Text] [Related]  

  • 11. Molecular mimicry between gangliosides and lipopolysaccharides of Campylobacter jejuni isolated from patients with Guillain-Barré syndrome and Miller Fisher syndrome.
    Yuki N
    J Infect Dis; 1997 Dec; 176 Suppl 2():S150-3. PubMed ID: 9396700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Campylobacter jejuni infection and Guillain-Barré syndrome.
    Rees JH; Soudain SE; Gregson NA; Hughes RA
    N Engl J Med; 1995 Nov; 333(21):1374-9. PubMed ID: 7477117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guillain-Barré syndrome associated with Campylobacter infection.
    Kuroki S; Haruta T; Yoshioka M; Kobayashi Y; Nukina M; Nakanishi H
    Pediatr Infect Dis J; 1991 Feb; 10(2):149-51. PubMed ID: 2062607
    [No Abstract]   [Full Text] [Related]  

  • 14. Campylobacter jejuni infection as a cause of the Guillain-Barré syndrome.
    Allos BM
    Infect Dis Clin North Am; 1998 Mar; 12(1):173-84. PubMed ID: 9494837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.
    Nachamkin I; Ung H; Moran AP; Yoo D; Prendergast MM; Nicholson MA; Sheikh K; Ho T; Asbury AK; McKhann GM; Griffin JW
    J Infect Dis; 1999 May; 179(5):1183-9. PubMed ID: 10191221
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study between an outbreak of Guillain-Barre syndrome in Jilin, China, and preceding Campylobacter jejuni infection.
    Zhang M; Li Q; He L; Meng F; Gu Y; Zheng M; Gong Y; Wang P; Ruan F; Zhou L; Wu J; Chen L; Fitzgerald C; Zhang J
    Foodborne Pathog Dis; 2010 Aug; 7(8):913-9. PubMed ID: 20455754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The risk of Guillain-Barré syndrome following infection with Campylobacter jejuni.
    McCarthy N; Andersson Y; Jormanainen V; Gustavsson O; Giesecke J
    Epidemiol Infect; 1999 Feb; 122(1):15-7. PubMed ID: 10098780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-infection with two different Campylobacter jejuni strains in a patient with the Guillain-Barré syndrome.
    Godschalk PC; Gilbert M; Jacobs BC; Kramers T; Tio-Gillen AP; Ang CW; Van den Braak N; Li J; Verbrugh HA; Van Belkum A; Endtz HP
    Microbes Infect; 2006 Jan; 8(1):248-53. PubMed ID: 16213180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of bacterial strains to clinical syndromes of Campylobacter-associated neuropathies.
    Kimoto K; Koga M; Odaka M; Hirata K; Takahashi M; Li J; Gilbert M; Yuki N
    Neurology; 2006 Nov; 67(10):1837-43. PubMed ID: 17130419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of Campylobacter jejuni/C.coli infection in patients with Guillain-Barré syndrome by serology and culture.
    Hariharan H; Naseema K; Kumaran C; Shanmugam J; Nair MD; Radhakrishnan K
    New Microbiol; 1996 Jul; 19(3):267-71. PubMed ID: 8841044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.